Effect of perioperative aspirin continuation on bleeding after pneumonectomy

Author:

Chen Qirui1ORCID,Liu Yan2,Liu Yi1,Ji Ying1,Ye Xin1,Li Xin1,Fu Yili1,Miao Jinbai1,Hou Shengcai1,Hu Bin1

Affiliation:

1. Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao‐Yang Hospital Capital Medical University Beijing China

2. Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao‐Yang Hospital Capital Medical University Beijing China

Abstract

AbstractBackgroundTo investigate the effect of continuous oral aspirin in perioperative period on bleeding in pneumonectomy.MethodsA total of 170 patients who underwent pneumonectomy in our hospital from March 2021 to March 2022 were selected as the study objects. All patients took oral aspirin before surgery and did not take other antiplatelet agent or anticoagulants at the same time. The continuation group included 85 cases and continued to take aspirin 100 mg/day during the perioperative period, and the interruption group included 85 cases who stopped aspirin for 7 days before surgery and 3 days after surgery, without bridging therapy. The intraoperative blood loss, operation time, conversion to thoracotomy rate, postoperative bleeding rate, blood transfusion rate, thrombotic events, postoperative drainage volume, length of hospital stay, and total hospital cost of the two groups were compared.ResultsThere were no statistically significant differences in intraoperative blood loss, operative time, rate of conversion to open, postoperative drainage, hospital stay, and cost between the two groups (p > 0.05), and there were no reoperations due to bleeding between the two groups.ConclusionsAspirin should be continued throughout the perioperative period in all high‐risk patients requiring pneumonectomy after balancing ischemic‐bleeding risks.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Reference24 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis

3. Clinical practice guidelines for management of dual antiplatelet therapy in patients with noncardiac surgery: A critical appraisal using the AGREE II instrument

4. Perioperative Management of Antithrombotic Therapy

5. Shanghai Medical Association; Society of Cardiovascular Disease, Shanghai Medical Association; Society of Anesthesiology,Shanghai Medical Association; Shanghai General Surgery Clinical Quality Control Center; Shanghai Cardiovascular Internal Medicine Clinical Quality Control Center. Shanghai expert consensus on perioperative management of antithrombotic patients accepting non‐cardiac surgery;Society of Surgery;Chinese J Pract Surg,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3